scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1014690048 |
P356 | DOI | 10.1007/S002239900600 |
P698 | PubMed publication ID | 10024373 |
P2093 | author name string | Jones SJ | |
Glorieux FH | |||
Boyde A | |||
Travers R | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | osteogenesis imperfecta | Q749409 |
P304 | page(s) | 185-190 | |
P577 | publication date | 1999-03-01 | |
P1433 | published in | Calcified Tissue International | Q5018771 |
P1476 | title | The mineralization density of iliac crest bone from children with osteogenesis imperfecta | |
P478 | volume | 64 |
Q36447437 | A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism |
Q57667437 | A mouse model for spondyloepiphyseal dysplasia congenita with secondary osteoarthritis due to aCol2a1mutation |
Q33391406 | A reference database for the Stratec XCT-2000 peripheral quantitative computed tomography (pQCT) scanner in healthy children and young adults aged 6-19 years. |
Q34153396 | Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone |
Q46288750 | Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). |
Q43705379 | Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women |
Q59409627 | Animal models of osteogenesis imperfecta: applications in clinical research |
Q50555382 | Bisphosphonate-induced zebra lines in fibrous dysplasia of bone: histo-radiographic correlation in a case of McCune-Albright syndrome. |
Q38778771 | Bone Material Properties in Osteogenesis Imperfecta |
Q53101663 | Bone as a Composite Material |
Q37406080 | Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids |
Q38553653 | Bone mass and mineralization in osteogenesis imperfecta. |
Q38066387 | Bone mineralization: from tissue to crystal in normal and pathological contexts |
Q46289309 | Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34). |
Q38364893 | Bone's Material Constituents and their Contribution to Bone Strength in Health, Disease, and Treatment. |
Q35012002 | COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. |
Q33673233 | CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII |
Q50446581 | Changes in bone mineral and matrix in response to a soft diet. |
Q37380294 | Combination of nanoindentation and quantitative backscattered electron imaging revealed altered bone material properties associated with femoral neck fragility |
Q51019511 | Comparison of nanoindentation measurements between osteogenesis imperfecta Type III and Type IV and between different anatomic locations (femur/tibia versus iliac crest). |
Q64245176 | Current concepts in osteogenesis imperfecta: bone structure, biomechanics and medical management |
Q46403869 | Cyclic bisphosphonate therapy in osteogenesis imperfecta type V. |
Q28069101 | Demineralization-remineralization dynamics in teeth and bone |
Q46287296 | Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females |
Q53215245 | Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta. |
Q38697935 | From flat foot to fat foot: structure, ontogeny, function, and evolution of elephant "sixth toes". |
Q34285654 | High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage |
Q46025597 | High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1. |
Q50172805 | Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation |
Q57315014 | In vitro analysis of bone phenotypes in Col1a1 and Jagged1 mutant mice using a standardized osteoblast cell culture system |
Q30463549 | Increased susceptibility to microdamage in Brtl/+ mouse model for osteogenesis imperfecta |
Q73820921 | Intrapopulation variability in mineralization density at the human femoral mid-shaft |
Q37334366 | Makings of a brittle bone: Unexpected lessons from a low protein diet study of a mouse OI model |
Q89965054 | Management of Osteogenesis Imperfecta |
Q77884968 | Mechanical properties of skeletal bone in gene-mutated stöpsel(dtl28d) and wild-type zebrafish (Danio rerio) measured by atomic force microscopy-based nanoindentation |
Q36803790 | Moderate chronic kidney disease impairs bone quality in C57Bl/6J mice |
Q46288286 | Morphologic detail of aging bone in human vertebrae |
Q31161912 | Musculoskeletal responses of 2-year-old Thoroughbred horses to early training. 8. Quantitative back-scattered electron scanning electron microscopy and confocal fluorescence microscopy of the epiphysis of the third metacarpal bone |
Q73820910 | Nanomechanical properties and mineral concentration in articular calcified cartilage and subchondral bone |
Q33926385 | Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse |
Q37135434 | Osteogenesis Imperfecta: update on presentation and management |
Q59409624 | Osteogenesis imperfecta |
Q34316613 | Osteogenesis imperfecta |
Q52655586 | Osteogenesis imperfecta and therapeutics. |
Q33488466 | Ovariectomy vs. hypofunction: their effects on rat mandibular bone. |
Q91890342 | PYY is a negative regulator of bone mass and strength |
Q43902519 | Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response |
Q91828269 | Phenotypic Properties of Collagen in Dentinogenesis Imperfecta Associated with Osteogenesis Imperfecta |
Q35742979 | Reduced diaphyseal strength associated with high intracortical vascular porosity within long bones of children with osteogenesis imperfecta |
Q35731108 | Relationship of bone mineralization density distribution (BMDD) in cortical and cancellous bone within the iliac crest of healthy premenopausal women. |
Q46292105 | Significant deterioration in nanomechanical quality occurs through incomplete extrafibrillar mineralization in rachitic bone: evidence from in-situ synchrotron X-ray scattering and backscattered electron imaging |
Q46294748 | Skeletal mineralization defects in adult hypophosphatasia--a clinical and histological analysis. |
Q50660578 | Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. |
Q28075733 | Synchrotron Imaging Assessment of Bone Quality |
Q51585765 | Synchrotron x-ray microtomographic investigation of mineral concentrations at micrometre scale in sound and carious enamel. |
Q33781943 | The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment. |
Q28767542 | The real response of bone to exercise |
Q51210954 | Three-dimensional study of human dental fissure enamel by synchrotron X-ray microtomography. |
Q36125953 | Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice. |
Q57168344 | Zebrafish type I collagen mutants faithfully recapitulate human type I collagenopathies |
Search more.